Skip to main content

BIO Names Kay Hagan Legislator of the Year

 

Senator Kay Hagan has earned praise for her work to get new potentially life-saving drugs to patients faster.

The Biotechnology Industry Organization gave Hagan one of its Legislator of the Year awards on Wednesday in Washington D.C.

Tags: 

Mid-Atlantic Bio 2012

Thursday, September 27, 2012 8:00am

 

Leaders, Entrepreneurs, Partners and More: Live Blog from #LSC2012

2:15 pm
A big thank you to the more than 950 people who made or annual celebration of life science a success. The team at CED had been a fantastic partner for this event for 21 years.

>

1:55 pm
Deborah Dunsire of Millennium echoes a phrase i've heard several times at this conference.

Inflection point.

PPD Expands Global Reach

Wilmington-based contract research organization PPD has expanded its global reach by opening an office in Tokyo, Japan, and completing the acquisition of AbC.R.O., a contract research organization with operations in Central and Eastern Europe.

The Tokyo office expands PPD's Phase II-IV clinical development services in response to growing client demand in East Asia. PPD will provide clinical management services in key therapeutic areas from this location.

SE BIO Web Site Set; Biz Competition Deadline March 30

Southeast BIO (SE BIO), the nonprofit organization supporting growth of the life sciences in the Southeast, has launched Southeast BIOtech Connect, an interactive database that outlines more than 1,200 biotech companies and centers throughout North Carolina, South Carolina, Alabama, Florida, Georgia, Tennessee and Virginia.

The launch of Southeast BIOtech Connect coincides with the fact that the 2009 BIO International Convention is being held this year in the Southeast -- in Atlanta, May 18 to 21, sponsored by the Biotechnology Industry Organization (BIO).

Triangle Business Journal: The Hamner May Add 400 Jobs, Labs with China Pact

The Hamner Institutes for Health Sciences could add 400 research workers to occupy a new 100,000-square-foot building on its Research Triangle Park campus if a tentative drug development agreement is finalized with China's leading medical research park, according to an exclusive report in Triangle Business Journal.

GSK Pays $667M for Drug Rights

GlaxoSmithKline (GSK), which maintains its U.S. headquarters in the Triangle, is adding new drugs to its lineup and expanding its reach in emerging markets through acquisition rather than development.

GSK plans to spend $667 million to acquire certain drugs and distribution rights to those drugs from Belgium-based UCB.

The deal also includes some 50 UCB operations in the Far-East, Middle-East, Latin America and Africa.

Pages

Subscribe to RSS - External